Data / New clinical trials / Colonic Neoplasms
Colonic Neoplasms trials: 250 new since Nov 2024
The full list. New Colonic Neoplasms clinical trials: 250 rows for $12.50, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 9 rows a month. The new rows come each week by email, $19 a month.
Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.
For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/colonic-neoplasms, and every list with its row count and price is at https://specstream.ai/data/lists.json.
Updated October 29, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).
250 clinical studies in Colonic Neoplasms were first posted on ClinicalTrials.gov from November 12, 2024 to October 29, 2026; 44 have an industry sponsor and 172 are recruiting or about to. The newest, NCT07904130, was posted on October 29, 2026: Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy Combined With Penpulimab and Fruquintinib... (West China Hospital).
The request: Every new Colonic Neoplasms clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.
- 250New trials
- 44Industry sponsored
- 172Recruiting or not yet
- October 29, 2026Latest posted
Newest trials
The newest 100 of 250, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.
| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
|---|---|---|---|---|---|---|---|---|---|
| October 29, 2026 | NCT07904130 | Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy Combined With Penpulimab and Fruquintinib for Advanced Colorectal Cancer | West China Hospital | Phase 2 | Not yet recruiting | Colo-rectal Cancer | 32 | clinicaltrials.gov | |
| October 28, 2026 | NCT07900620 | T1 Colorectal Cancer After Local Excision: Decision Between Surgery and Active Surveillance (T1LDA Trial) | Tampere University Hospital | Not applicable | Not yet recruiting | Colorectal Cancer | 500 | Finland | clinicaltrials.gov |
| October 28, 2026 | NCT07900165 | Study of Varsetatug Masetecan in Combination With Anti-Cancer Therapies in Colorectal Cancer | CytomX Therapeutics | Phase 1/2 | Not yet recruiting | Colo-rectal Cancer | 368 | clinicaltrials.gov | |
| October 27, 2026 | NCT07897721 | A Study to Learn About the Study Medicine Called PF-08165784 in People With PIK3CA-Mutated Advanced or Metastatic Solid Tumors | Pfizer | Phase 1 | Not yet recruiting | Advanced Breast Cancer, Advanced or Metastatic Breast Cancer, Metastatic Breast Cancer (HR+/ HER2-), Metastatic... | 268 | clinicaltrials.gov | |
| October 27, 2026 | NCT07896681 | Toripalimab Plus Cetuximab and Irinotecan for Second-Line Right-Sided RAS/BRAF Wild-Type Advanced Colon Cancer Phase II Study | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 | Recruiting | Colorectal Cancer (CRC) | 46 | China | clinicaltrials.gov |
| October 20, 2026 | NCT07882069 | Effect of ACTIVE-Care on Cancer-Related Fatigue, Hope, and Psychological Resilience in Adolescents With Acute Lymphoblastic Leukemia | Selcuk University | Not applicable | Completed | Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma), Adolescent, Resilience... | 70 | Turkey (Türkiye) | clinicaltrials.gov |
| October 19, 2026 | NCT07881133 | Perioperative Biomarkers in Colorectal and Gastric Cancer Surgery | Bucharest Emergency Hospital | Not applicable | Recruiting | Colorectal (Colon or Rectal) Cancer, STOMACH NEOPLASM | 320 | Romania | clinicaltrials.gov |
| October 16, 2026 | NCT07878988 | This is a Phase 1/1b Study to Evaluate the Safety and Preliminary Antitumor Activity of LTZ-232 in Participants With Advanced/Metastatic... | LTZ Therapeutics, Inc. | Phase 1 | Recruiting | Colorectal Cancer, Advanced/Metastatic Solid Tumor, Solid Tumor (Phase I), EPCAM, Colon Cancer | 152 | United States | clinicaltrials.gov |
| October 16, 2026 | NCT07877597 | Chemotherapy Combined With or Without Short-Course Radiotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for High-Risk Locally... | Fudan University | Phase 3 | Not yet recruiting | Locally Advanced Colon Cancer, pMMR | 480 | China | clinicaltrials.gov |
| October 14, 2026 | NCT07872787 | NURSE-led Geriatric Assessment in Older Colorectal Cancer Patients | Helse Stavanger HF | Not applicable | Not yet recruiting | Colo-rectal Cancer | 50 | Norway | clinicaltrials.gov |
| September 30, 2026 | NCT07850778 | ONS USE IN COLON CANCER | Osmaniye Korkut Ata University | Observational | Completed | Oral Nutritional Supplementation, Colon Cancer | 209 | Turkey (Türkiye) | clinicaltrials.gov |
| September 29, 2026 | NCT07847216 | Multicenter Prospective Study Protocol for Validating Surgical Quality Standards in D3 Lymphadenectomy for Oncological Right Hemicolectomy | Fundació d'investigació Sanitària de les Illes Balears | Observational | Not yet recruiting | Colon Neoplasms, Right Colon Tumors, Lymphadenectomy | 120 | clinicaltrials.gov | |
| September 25, 2026 | NCT07841236 | ctDNA-Guided Immunotherapy for dMMR/MSI-H Colon Cancer | Fudan University | Phase 2 | Recruiting | Colon Cancer, Deficient Mismatch Repair, Microsatellite Instability-High (MSI-H) | 23 | China | clinicaltrials.gov |
| September 25, 2026 | NCT07840677 | Tafolecimab Combined With Chemoimmunotherapy as Neoadjuvant Treatment for pMMR/MSS Locally Advanced Colon Cancer | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Phase 2 | Recruiting | Colon Cancer, PCSK9 Inhibitor, Neoadjuvant Immunochemotherapy | 70 | China | clinicaltrials.gov |
| September 18, 2026 | NCT07827378 | Early Discharge After Colorectal Surgery | Fundación para la Investigación del Hospital Clínico de Valencia | Observational | Not yet recruiting | Cancer, Colo-rectal Cancer | 97 | clinicaltrials.gov | |
| September 17, 2026 | NCT07825766 | The Role of Total Abdominal Autonomic Nerve Preservation During the Resection of Right/Left Colon Cancer: Prospective Clinical Trial | Fudan University | Observational | Active not recruiting | Colon Cancer, Nerve Preserve | 200 | China | clinicaltrials.gov |
| September 16, 2026 | NCT07823322 | A Study to Evaluate INCA33890 in the Treatment of Circulating Tumor DNA-Positive Stage II/III Microsatellite Stable Colorectal Cancer After... | Incyte Corporation | Phase 2 | Not yet recruiting | CRC (Colorectal Cancer) | 40 | clinicaltrials.gov | |
| September 15, 2026 | NCT07821333 | Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II-III | Fundación para la Investigación del Hospital Clínico de Valencia | Phase 2 | Active not recruiting | Colorectal Neoplasms Malignant, Minimal Residual Disease, Circulating Tumor Cell | 45 | Spain | clinicaltrials.gov |
| September 8, 2026 | NCT07808151 | Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer | Solstice Oncology, Inc. | Phase 2 | Recruiting | Colon Cancer | 100 | Belgium, Italy, Netherlands, Spain, United Kingdom, United States | clinicaltrials.gov |
| September 4, 2026 | NCT07805369 | A Phase 1 Study of DEM301 in Participants With Metastatic Colorectal Cancer | DEM BioPharma, Inc. | Phase 1 | Recruiting | Metastatic Colorectal Cancer, Colon Cancer, Rectal Cancer | 60 | Australia | clinicaltrials.gov |
| September 3, 2026 | NCT07802847 | Innovative and Cooperative Pathway Integrating Oncogeriatric, Pharmaceutical and Pharmacological Follow-up in Elderly Patients. | Gustave Roussy, Cancer Campus, Grand Paris | Phase 4 | Not yet recruiting | Elderly, Breast Cancer, Lung Cancer, Prostate Cancer, Colon Cancer, Kidney Cancer, Sarcoma | 794 | France | clinicaltrials.gov |
| August 31, 2026 | NCT07795528 | Postoperative Circulating Tumor DNA Monitoring in Stage I-III Driver-Mutant Colon Adenocarcinoma | Ruijin Hospital | Observational | Recruiting | Colon Adenocarcinoma, Stage I Colon Cancer, Stage II Colon Cancer, Stage III Colon Cancer | 392 | China | clinicaltrials.gov |
| August 28, 2026 | NCT07792980 | AI-Assisted Microbiome Analysis for Evaluating the Efficacy of MPRO3 and Gut Environmental Changes in Colon Cancer Surgery Patients | hy Co., LTD. | Not applicable | Recruiting | Colon Neoplasms | 100 | South Korea | clinicaltrials.gov |
| August 24, 2026 | NCT07781774 | Improving Colorectal Cancer Screening Uptake Through Education and Stool-Based Testing Outreach | Washington University School of Medicine | Not applicable | Not yet recruiting | Colorectal Cancer (CRC) Screening, CRC Screening, Rectal Cancer, Colon Cancer, Colorectal Cancer | 200 | United States | clinicaltrials.gov |
| August 21, 2026 | NCT07778628 | WT1 in Colorectal Adenocarcinoma | Sohag University | Observational | Completed | Colorectal Cancer | 60 | Egypt | clinicaltrials.gov |
| August 10, 2026 | NCT07756450 | Impact of Obesity on Textbook Outcome Achievement in Minimally Invasive Colorectal Cancer Surgery | Bakirkoy Dr. Sadi Konuk Research and Training Hospital | Observational | Completed | Minimally Invasive Surgical Procedures, Colo-rectal Cancer | 305 | Turkey (Türkiye) | clinicaltrials.gov |
| August 7, 2026 | NCT07751783 | Development and Dissemination of Exercise Prescription and Intervention for Cancer Populations | Kaohsiung Medical University Chung-Ho Memorial Hospital | Not applicable | Recruiting | Cancer, Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma), Lung Cancer... | 150 | Taiwan | clinicaltrials.gov |
| August 4, 2026 | NCT07744139 | Radiogenomic Profiling of Dendritic Cells and Macrophages to Predict Recurrence in Colorectal Liver Metastasis | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Not yet recruiting | Colo-rectal Cancer, Liver Metastases, Colon Cancer | 210 | clinicaltrials.gov | |
| July 30, 2026 | NCT07736131 | Learning Curve of SILS in CRC | Ruijin Hospital | Observational | Completed | Rectal Cancer, Colon Cancer, Single Port Laparoscopy | 280 | clinicaltrials.gov | |
| July 29, 2026 | NCT07733817 | Impact of Probiotics on Neuropathy Induced by Adjuvant Chemotherapy in Patients With Colon Cancer. | Centre Francois Baclesse | Not applicable | Not yet recruiting | Colon Adenocarcinoma, Neuropathic Pain | 130 | France | clinicaltrials.gov |
| July 29, 2026 | NCT07732686 | Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry | University of Oklahoma | Observational | Not yet recruiting | Pancreas Cancer, Hepatocellular Carcinoma, Lung Cancer, Ovarian Cancer, Breast Cancer, Head and Neck Cancer, Colon... | 2,000 | United States | clinicaltrials.gov |
| July 24, 2026 | NCT07725692 | Predictors of Rescue Surgery, Mortality, and Permanent Stoma After Anastomotic Leak Following Colorectal Cancer Resection | Alexandria University | Observational | Completed | Anastomotic Leak, Colorectal Cancer, Colon Cancer, Postoperative Complication, Intestinal Stoma | 3,200 | Egypt | clinicaltrials.gov |
| July 23, 2026 | NCT07722754 | Bevacizumab, Sintilimab, Cetuximab and Irinotecan in Refractory RAS Wild-type Metastatic Colorectal Cancer: BOND-4 Trial | Guangdong Provincial People's Hospital | Phase 2 | Recruiting | Colorectal Neoplasms Malignant, Neoplasm, Metastatic | 160 | China | clinicaltrials.gov |
| July 22, 2026 | NCT07720505 | COLOFLOW: Laser Speckle Contrast Imaging Versus Near-infrared Fluorescence Imaging With Indocyanine Green | Leiden University Medical Center | Observational | Not yet recruiting | Leakage, Anastomotic, Colon Cancer, Colon Anastomosis, Colon and Rectal Cancer, Colon Benign Tumor, Colon and Rectal... | 30 | clinicaltrials.gov | |
| July 22, 2026 | NCT07718919 | Multicentric National Italian Analysis of Textbook Outcome in Colorectal Cancer Surgery | Academy of Applied Medical and Social Sciences, Poland | Observational | Completed | Colo-rectal Cancer | 6,129 | Italy | clinicaltrials.gov |
| July 20, 2026 | NCT07713472 | Abdominal Massage After Colon Surgery for Cancer | University Hospital, Grenoble | Not applicable | Not yet recruiting | Colonic Cancer | 225 | France | clinicaltrials.gov |
| July 17, 2026 | NCT07709923 | Predictive Model For Anastomotic Leakage After Colorectal Cancer Surgery | University of Foggia | Observational | Completed | Colorectal (Colon or Rectal) Cancer, Leak, Anastomotic, Surgery Complications | 117 | Italy | clinicaltrials.gov |
| July 15, 2026 | NCT07705334 | A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors | SHY Therapeutics | Phase 1 | Recruiting | Advanced or Metastatic Solid Tumors, Triple Negative Breast Cancer (TNBC), HR+ Breast Cancer, Colon Cancer, Gastric... | 30 | United States | clinicaltrials.gov |
| July 14, 2026 | NCT07701408 | ctDNA and TEP Levels in Colon Cancer | Institute of Oncology Ljubljana | Not applicable | Not yet recruiting | Colon Cancer | 80 | Slovenia | clinicaltrials.gov |
| July 13, 2026 | NCT07697170 | Frequency of Care for Peripherally Inserted Central Vascular Access In the Prevention of Marsi | Institut Català d'Oncologia | Not applicable | Enrolling by invitation | Colon Cancer, Cancer Pancreas | 150 | Spain | clinicaltrials.gov |
| July 9, 2026 | NCT07691489 | A Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancer | Memorial Sloan Kettering Cancer Center | Phase 2 | Not yet recruiting | Colorectal Cancer, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | 27 | United States | clinicaltrials.gov |
| June 30, 2026 | NCT07675967 | Clonal Hematopoiesis Chemotherapy and Radiation Effects Study | Dana-Farber Cancer Institute | Observational | Recruiting | Lung Cancer (Diagnosis), Osteochondroma, Spitz Nevus, Solid Cancers, Breast Cancer, Gastric (Stomach) Cancer... | 5,000 | United States | clinicaltrials.gov |
| June 29, 2026 | NCT07673393 | Improving Prognostication in Colon Cancer | Universitaire Ziekenhuizen KU Leuven | Observational | Not yet recruiting | Colon Cancer, Colon Adenocarcinoma | 400 | clinicaltrials.gov | |
| June 25, 2026 | NCT07669519 | Evaluation of NuvastaticTM in Reducing Cancer-Related Fatigue in Colon Cancer Patients Undergoing First-Line Chemotherapy | Natureceuticals Sdn Bhd | Phase 3 | Recruiting | Fatigue, Colon Cancer | 180 | India | clinicaltrials.gov |
| June 25, 2026 | NCT07669454 | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative, Phase III Study to Evaluate the Efficacy and Safety of... | Natureceuticals Sdn Bhd | Phase 3 | Recruiting | Fatigue Related to Cancer Treatment, Colon Cancer | 250 | India | clinicaltrials.gov |
| June 18, 2026 | NCT07656740 | Non-Operative Management and Following Immunotherapy for Colorectal Cancer and Other GI Cancers | Peking University Cancer Hospital & Institute | Observational | Not yet recruiting | Gastrointestinal Cancer, Colorectal (Colon or Rectal) Cancer, Stomach (Gastric) Cancer | 50 | China | clinicaltrials.gov |
| June 16, 2026 | NCT07649473 | QL1706 Combined With Standard Therapy for Conversion Therapy of Synchronous Liver Metastases From Colon Cancer: a Multicenter, Single-arm... | Fujian Medical University | Phase 2 | Not yet recruiting | Colon Cancer, Synchronous Liver Metastases | 30 | China | clinicaltrials.gov |
| June 10, 2026 | NCT07638956 | ICG in Colon Cancer | Tanta University | Not applicable | Not yet recruiting | Colon Cancer, ICG (Indocyanine Green) | 25 | clinicaltrials.gov | |
| June 10, 2026 | NCT07638410 | Prehabilitation in High-risk Oncologic Surgery | Fox Chase Cancer Center | Not applicable | Recruiting | Pancreatic Cancer, Colo-rectal Cancer, Gastric Cancer, Esophageal Cancer, Bladder Cancer, Ovarian Cancer, Abdominal... | 180 | United States | clinicaltrials.gov |
| June 5, 2026 | NCT07629960 | A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations | Blueprint Medicines Corporation | Phase 1/2 | Recruiting | Advanced Solid Tumor, Non-Small Cell Lung Cancer, Colorectal Neoplasms, Pancreatic Ductal Adenocarcinoma | 265 | Spain, United States | clinicaltrials.gov |
| June 2, 2026 | NCT07620535 | Decision Counseling and Follow-up for Shield+ Patients | Guardant Health, Inc. | Observational | Not yet recruiting | Colo-rectal Cancer | 350 | United States | clinicaltrials.gov |
| May 19, 2026 | NCT07596732 | Statewide Unified Network for Remote Intervention of Strength and Exercise | AdventHealth Translational Research Institute | Not applicable | Not yet recruiting | Gastric Cancer (Diagnosis), Esophagus Cancer, Pancreas Cancer, Colon Cancer, Rectal Cancer, Lung Cancer | 120 | clinicaltrials.gov | |
| May 19, 2026 | NCT07595874 | Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3 | City of Hope Medical Center | Phase 2 | Recruiting | Advanced Colon Adenocarcinoma, Advanced Colorectal Adenocarcinoma, Advanced Rectal Adenocarcinoma, Stage IIB Colon... | 100 | United States | clinicaltrials.gov |
| May 19, 2026 | NCT07594626 | BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion | Northwestern University | Phase 1/2 | Recruiting | Metastatic Biliary Tract Carcinoma, Metastatic Colon Carcinoma, Metastatic Esophageal Carcinoma, Metastatic Malignant... | 72 | United States | clinicaltrials.gov |
| May 4, 2026 | NCT07565831 | Study on the Prediction of Regional Lymph Node Metastasis in Colorectal Cancer by Spectral CT Combined With MSI | Yunnan Cancer Hospital | Not applicable | Active not recruiting | Colo-rectal Cancer | 260 | China | clinicaltrials.gov |
| April 29, 2026 | NCT07555639 | An Integrated Genomic Approach to Assess Genetic Risk and Drug Sensitivity | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Not applicable | Active not recruiting | Colon Cancer, Breast Cancer, Ovarian Cancer, Genetic Risk Factors | 4,000 | Italy | clinicaltrials.gov |
| April 24, 2026 | NCT07549906 | Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR... | Sun Yat-sen University | Phase 2 | Not yet recruiting | Colon Cancer (Stage II &Amp; III), Immunotherapy, Beta Blocker, Neoadjuvant Chemoimmunotherapy | 45 | clinicaltrials.gov | |
| April 22, 2026 | NCT07546565 | Mechanical Bowel Preparation in Laparoscopic Right Hemicolectomy With Intracorporeal Anastomosis | University Medical Center Ho Chi Minh City (UMC) | Not applicable | Recruiting | Colon Cancer | 74 | Vietnam | clinicaltrials.gov |
| April 21, 2026 | NCT07541105 | Cancer Awareness Among Syrian Migrants | Toros University | Not applicable | Not yet recruiting | Breast Cancer Screening, Cervical Cancer Screening, Colorectal Cancer Screening, Cancer Prevention Behavior | 30 | clinicaltrials.gov | |
| April 16, 2026 | NCT07534852 | NIMA-Colon Cancer Study | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | Not applicable | Recruiting | Colon Cancer | 120 | Spain | clinicaltrials.gov |
| April 14, 2026 | NCT07529808 | Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma | BigHat Biosciences, Inc. | Phase 1/2 | Recruiting | Gastric Cancer, Gastric Adenocarcinoma, Gastric (Stomach) Cancer, Gastroesophageal Adenocarcinoma, Gastroesophageal... | 164 | United States | clinicaltrials.gov |
| April 14, 2026 | NCT07528937 | Application of 3D Reconstruction for Preoperative Strategy of Locally Advanced Colon Cancer | Fundació d'investigació Sanitària de les Illes Balears | Not applicable | Not yet recruiting | Colon Neoplasms, Locally Advanced Colon Cancer, 3D Reconstruction | 168 | clinicaltrials.gov | |
| April 8, 2026 | NCT07517848 | Comparison of the Left-Lateral Horizontal and Supine Positions for Colonoscopy Intervention: A Randomized Controlled Study | Manisa Celal Bayar University | Not applicable | Completed | Colorectal Disorders, Colorectal Neoplasms, Colorectal Polyp, Colo-rectal Cancer | 198 | Turkey (Türkiye) | clinicaltrials.gov |
| April 7, 2026 | NCT07515963 | FULIRI Plus Targeted Therapy for First-line Conversion Therapy of Colorectal Cancer Liver Metastases. | Zhongnan Hospital | Phase 2 | Not yet recruiting | Colo-rectal Cancer | 24 | China | clinicaltrials.gov |
| April 6, 2026 | NCT07512726 | DevelopmentA Web-Based Support Care Program for Individuals Diagnosed With Colorectal Cancer | Ilknur Yazicioglu | Not applicable | Completed | Colorectal Cancer, Colorectal (Colon or Rectal) Cancer | 24 | Turkey (Türkiye) | clinicaltrials.gov |
| April 6, 2026 | NCT07510932 | Fruquintinib In Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies in South Korea Patients (FIRST-K) | Korea University Anam Hospital | Phase 2 | Not yet recruiting | Colon Cancer | 88 | clinicaltrials.gov | |
| April 2, 2026 | NCT07508592 | Feasibility Study of the SEGER Device in Laparoscopic Gastrointestinal Surgery | Seger Surgical Solutions | Not applicable | Completed | Colon Neoplasms, Crohn Disease (CD), Obesity & Overweight | 10 | El Salvador | clinicaltrials.gov |
| April 2, 2026 | NCT07508046 | Clinical Study on the Expression of PHGDH and Its Prognostic Value in Colorectal Cancer Patients Receiving Immunotherapy | West China Hospital | Observational | Completed | Colo-rectal Cancer | 100 | China | clinicaltrials.gov |
| March 31, 2026 | NCT07503847 | Shared Decision-Making for Colorectal Cancer Screening in High-Risk First-Degree Relatives Aged 40-49 | National Taiwan University Hospital | Not applicable | Enrolling by invitation | Colo-rectal Cancer, Shared Decision Making, Patient Decision Aid | 2,286 | Taiwan | clinicaltrials.gov |
| March 31, 2026 | NCT07502469 | Study Comparing the Contribution of G-Eye Combined With CAD-Eye Versus High-definition Colonoscopy With CAD-Eye in the Detection of Colonic... | Elsan | Observational | Completed | Colorectal Cancer, Colo-rectal Cancer | 341 | France | clinicaltrials.gov |
| March 27, 2026 | NCT07494578 | Observational Study Regarding the Combination of Fluoropyrimidine and Bevacizumab in Patients With mCRC | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Active not recruiting | Colon Cancer Metastatic | 300 | Italy | clinicaltrials.gov |
| March 27, 2026 | NCT07494201 | MIMICC Study in Patients With Colorectal Cancer | Fondazione del Piemonte per l'Oncologia | Not applicable | Recruiting | Colorectal Cancer, Colon Cancer, Rectal Cancers | 2,500 | Italy | clinicaltrials.gov |
| March 16, 2026 | NCT07474025 | Biopsy-Resection Agreement of Peritoneal Histopathological Growth Patterns in Colorectal Peritoneal Metastases: A Prospective Observational... | Jules Bordet Institute | Observational | Recruiting | Peritoneal (Metastatic) Cancer, Colorectal Cancer, Colorectal (Colon or Rectal) Cancer, Histopathological Growth... | 30 | Belgium | clinicaltrials.gov |
| March 13, 2026 | NCT07470658 | Optimal Surveillance Strategy After Positive FIT and Negative Colonoscopy | National Taiwan University Hospital | Observational | Enrolling by invitation | Advanced Colorectal Cancer, Colo-rectal Cancer, Fecal Immunochemical Test | 1,274 | Taiwan | clinicaltrials.gov |
| March 13, 2026 | NCT07469709 | A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks | Fondazione del Piemonte per l'Oncologia | Observational | Recruiting | Breast Cancer, Colo-rectal Cancer, Ovarian Cancer, Melanoma (Skin Cancer), Non-Small Cell Lung Cancer (MeSH Term... | 850 | Italy | clinicaltrials.gov |
| March 12, 2026 | NCT07468630 | Tolecizumab Plus Chemoimmunotherapy for pMMR/MSS Locally Advanced Colon Adenocarcinoma | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Phase 2 | Recruiting | Colon Adenocarcinoma | 106 | China | clinicaltrials.gov |
| March 10, 2026 | NCT07462650 | Dual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal Cancer | Beijing Biotech | Phase 1/2 | Recruiting | Colorectal Cancer Metastatic, Adenocarcinoma of Colon | 48 | China | clinicaltrials.gov |
| March 10, 2026 | NCT07462143 | A Phase Ⅱ/Ⅲ Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or Metastatic Colorectal Cancer | RemeGen Co., Ltd. | Phase 2/3 | Recruiting | Colorectal (Colon or Rectal) Cancer | 80 | China | clinicaltrials.gov |
| March 9, 2026 | NCT07458347 | A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral... | Kestrel Therapeutics, Inc. | Phase 1 | Recruiting | KRAS-mutant Non-small Cell Lung Cancer (NSCLC), KRAS-mutant Pancreatic Ductal Adenocarcinoma (PDAC), KRAS-mutant... | 545 | United States | clinicaltrials.gov |
| March 9, 2026 | NCT07457112 | EHealth Educational Intervention to Improve Self-Management and Coping Behaviors Among Cancer Patients | Zagazig University | Not applicable | Completed | Cancer, Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma) | 212 | Egypt | clinicaltrials.gov |
| March 4, 2026 | NCT07450612 | Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection | San Raffaele University | Observational | Recruiting | Colorectal Cancer, Adenoma Colon, Adenoma Colon Polyp, Colon Adenoma, Colo-rectal Cancer, Colon Disease, Colon... | 1,200 | Italy | clinicaltrials.gov |
| March 4, 2026 | NCT07448662 | Local Treatment Strategies for Brain Metastases of Colorectal Cancer | Blokhin's Russian Cancer Research Center | Observational | Active not recruiting | Colorectal Cancer, Brain Metastases, Adult | 700 | Belarus, Russia | clinicaltrials.gov |
| March 3, 2026 | NCT07445178 | Piecemeal Resection and Advanced Histology Independently Predict Local Recurrence After Colorectal Snare-based Endoscopic Resection: a... | University of Sao Paulo | Observational | Completed | Colo-rectal Cancer | 255 | Brazil | clinicaltrials.gov |
| February 27, 2026 | NCT07440888 | The Factors Influencing the Success of Redo Surgery and Anal Function for Anastomosis Failure or Local Tumor Recurrence | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Observational | Completed | Colo-rectal Cancer, Anastomosis, Leaking | 143 | clinicaltrials.gov | |
| February 27, 2026 | NCT07436312 | Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer | Gustave Roussy, Cancer Campus, Grand Paris | Not applicable | Recruiting | Breast Cancer, Pancreas Cancer, Colon Cancer, Lynch Syndrome, Germline BRCA1 Gene Mutation, Germline BRCA2 Gene Mutation | 170 | France | clinicaltrials.gov |
| February 25, 2026 | NCT07432399 | Effect of Perioperative Lidocaine or High-Dose Dexamethasone on Immune Response in Colon Cancer Surgery (PILDI Study) | Institute of Oncology Ljubljana | Phase 2 | Recruiting | Colon Cancer, Colorectal Cancer, Perioperative Immune Response | 100 | Slovenia | clinicaltrials.gov |
| February 23, 2026 | NCT07428239 | Pilot Study of Individualized Comprehensive Rehabilitation in Patients With Colorectal Cancer | Institute of Oncology Ljubljana | Not applicable | Completed | Colon Cancer, Rectal Cancer | 150 | Slovenia | clinicaltrials.gov |
| February 23, 2026 | NCT07427901 | Quality Of Life In Colorectal Cancer Survivors | Institute of Oncology Ljubljana | Not applicable | Recruiting | Colorectal Cancer, Colon Cancer, Rectal Cancer | 368 | Slovenia | clinicaltrials.gov |
| February 23, 2026 | NCT07427537 | Exploration of Circulating microRNAs as Biomarkers of Chemo-induced Peripheral Neuropathy: a Study in Cancer Patients | University Hospital, Clermont-Ferrand | Not applicable | Recruiting | Cancer, Lung, Colon Neoplasm, Neuropathy;Peripheral | 90 | France | clinicaltrials.gov |
| February 19, 2026 | NCT07420010 | An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032... | Weijia Fang, MD | Early phase 1 | Not yet recruiting | Ovarian Cancer, Mesothelioma, Colon Cancer | 24 | clinicaltrials.gov | |
| February 19, 2026 | NCT07419490 | Utero-ovarian Transposition in Patients With Pelvic Malignancies Undergoing Whole Pelvic Radiotherapy | University of South Florida | Not applicable | Recruiting | Colorectal (Colon or Rectal) Cancer, Pelvic Malignancies, Oncofertility | 26 | United States | clinicaltrials.gov |
| February 17, 2026 | NCT07414082 | Serum Talin-1 and Cripto-1 in Colorectal Cancer | Assiut University | Not applicable | Not yet recruiting | Colo-rectal Cancer | 70 | Egypt | clinicaltrials.gov |
| February 17, 2026 | NCT07413146 | Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized... | Sun Yat-sen University | Not applicable | Not yet recruiting | Minimal Residual Disease, Immunoscore, Neoadjuvant Chemotherapy, Colon Cancer (Stage II &Amp; III) | 100 | clinicaltrials.gov | |
| February 13, 2026 | NCT07409844 | Neoadjuvant Immunotherapy and Organ-sparing Treatment in Patients With Stage I-III dMMR Colon Cancer | Ismail Gögenur | Phase 2 | Not yet recruiting | DMMR Colorectal Cancer, Colon Cancer Stage I, Colon Cancer Stage II/III, Pembrolizumab, Immunotherapy | 152 | Denmark | clinicaltrials.gov |
| February 12, 2026 | NCT07407465 | Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer. | Gruppo Oncologico del Nord-Ovest | Phase 2 | Recruiting | Colorectal Cancer, Colorectal Adenocarcinoma, Rectal Adenocarcinoma, Rectal Cancer, Adenocarcinoma, Rectal Cancer... | 42 | France, Germany, Italy, Spain | clinicaltrials.gov |
| February 12, 2026 | NCT07406958 | Advanced Classification of Colon Tumors From CT Scans Using Deep Learning for Optimized Treatment Decision-making. | Assistance Publique - Hôpitaux de Paris | Observational | Not yet recruiting | Colonic Neoplasm | 1,000 | France | clinicaltrials.gov |
| February 12, 2026 | NCT07406087 | Navigation Intervention for Adolescent and Young Adult Cancer Survivors | Kaiser Permanente | Not applicable | Recruiting | Breast Cancer, Ovarian Cancer, Cervical Cancer, Testicular Cancer, Colon Rectal Cancer, Melanoma (Skin Cancer)... | 25 | United States | clinicaltrials.gov |
| February 12, 2026 | NCT07405931 | Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients | Ulsan University Hospital | Not applicable | Recruiting | Early Gastric Cancer, Advanced Gastric Cancer, Early Lung Cancer, Advanced Lung Cancer, Early Breast Cancer, Advanced... | 414 | South Korea | clinicaltrials.gov |
| February 12, 2026 | NCT07405476 | Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment | Emory University | Phase 2 | Recruiting | Colon Carcinoma, Colorectal Carcinoma, Rectal Carcinoma, Stage I Colon Cancer AJCC v8, Stage I Colorectal Cancer AJCC... | 38 | United States | clinicaltrials.gov |
| February 4, 2026 | NCT07387263 | Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing | Unity Health Toronto | Not applicable | Recruiting | Cancer, Breast Cancer, Prostate Cancer, Colon Cancer, GI Cancers, Ovarian Cancer, Pancreatic Cancer | 180 | Canada | clinicaltrials.gov |
Sponsors posting most
| Sponsor | New trials | Latest |
|---|---|---|
| Fudan University | 6 | October 16, 2026 |
| Institute of Oncology Ljubljana | 5 | July 14, 2026 |
| Sun Yat-sen University | 5 | April 24, 2026 |
| Pfizer | 4 | October 27, 2026 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 4 | October 27, 2026 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 4 | August 4, 2026 |
| West China Hospital | 3 | October 29, 2026 |
| Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 3 | September 25, 2026 |
| Ruijin Hospital | 3 | August 31, 2026 |
| City of Hope Medical Center | 3 | May 19, 2026 |
| Alliance for Clinical Trials in Oncology | 3 | December 16, 2025 |
| Sixth Affiliated Hospital, Sun Yat-sen University | 3 | December 12, 2025 |
| Seoul National University Hospital | 3 | January 6, 2025 |
| Fundació d'investigació Sanitària de les Illes Balears | 2 | September 29, 2026 |
| Fundación para la Investigación del Hospital Clínico de Valencia | 2 | September 18, 2026 |
| Incyte Corporation | 2 | September 16, 2026 |
| Gustave Roussy, Cancer Campus, Grand Paris | 2 | September 3, 2026 |
| Washington University School of Medicine | 2 | August 24, 2026 |
| Universitaire Ziekenhuizen KU Leuven | 2 | June 29, 2026 |
| Natureceuticals Sdn Bhd | 2 | June 25, 2026 |
By phase
| Phase | New trials | Latest |
|---|---|---|
| Not applicable | 87 | October 28, 2026 |
| Observational | 79 | September 30, 2026 |
| Phase 2 | 40 | October 29, 2026 |
| Phase 1 | 14 | October 27, 2026 |
| Phase 3 | 13 | October 16, 2026 |
| Phase 1/2 | 11 | October 28, 2026 |
| Phase 4 | 3 | September 3, 2026 |
| Phase 2/3 | 2 | March 10, 2026 |
| Early phase 1 | 1 | February 19, 2026 |
By country
| Country | New trials | Latest |
|---|---|---|
| United States | 57 | October 16, 2026 |
| China | 46 | October 27, 2026 |
| Italy | 22 | September 8, 2026 |
| Spain | 18 | September 15, 2026 |
| Turkey (Türkiye) | 16 | October 20, 2026 |
| France | 16 | September 3, 2026 |
| South Korea | 12 | August 28, 2026 |
| Brazil | 9 | March 3, 2026 |
| Germany | 8 | February 12, 2026 |
| Belgium | 7 | September 8, 2026 |
| Egypt | 7 | August 21, 2026 |
| Taiwan | 7 | August 7, 2026 |
| Netherlands | 6 | September 8, 2026 |
| Denmark | 6 | February 13, 2026 |
| Canada | 6 | February 4, 2026 |
| Australia | 5 | September 4, 2026 |
| Slovenia | 5 | July 14, 2026 |
| Japan | 5 | December 16, 2025 |
| Poland | 5 | December 16, 2025 |
| Puerto Rico | 5 | December 16, 2025 |
| United Kingdom | 4 | September 8, 2026 |
| Argentina | 4 | December 16, 2025 |
| Finland | 3 | October 28, 2026 |
| Russia | 3 | March 4, 2026 |
| Hong Kong | 3 | May 30, 2025 |
Where the register publishes
U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.